Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | ENPP2 | Q13822 | 7/20 | 0.46 |
| ▸ | CAPN1 | P07384 | 3/20 | 0.42 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | TEAD1 | P28347 | 2/20 | 0.40 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ITGAL | P20701 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6497665 | 1.00 | SMN1; SMN2 (0.48) | SMN1; SMN2ENPP2CAPN1BACE1KCNH2 | |
| SCHEMBL6504860 | 0.91 | ENPP2 (0.46) | SMN1; SMN2ENPP2CAPN1KCNH2KMT2A | |
| SCHEMBL6495356 | 0.90 | ENPP2 (0.46) | ENPP2CAPN1KCNH2KMT2ATEAD1 | |
| SCHEMBL6495354 | 0.90 | ENPP2 (0.46) | ENPP2CAPN1KCNH2KMT2ATEAD1 | |
| SCHEMBL6500473 | 0.87 | SMN1; SMN2 (0.66) | SMN1; SMN2CAPN1KMT2AC3AR1MEN1 | |
| SCHEMBL6500476 | 0.87 | SMN1; SMN2 (0.66) | SMN1; SMN2CAPN1KMT2AC3AR1MEN1 | |
| SCHEMBL6497183 | 0.84 | ITGAL (0.45) | SMN1; SMN2ENPP2CAPN1KMT2AMEN1 | |
| SCHEMBL6497179 | 0.84 | ITGAL (0.45) | SMN1; SMN2ENPP2CAPN1KMT2AMEN1 | |
| SCHEMBL6504618 | 0.83 | CAPN1 (0.46) | SMN1; SMN2CAPN1KMT2AC3AR1MEN1 | |
| SCHEMBL6504616 | 0.83 | CAPN1 (0.46) | SMN1; SMN2CAPN1KMT2AC3AR1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005016883-A2 | ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF | ICOS CORPORATION (US) | 2005-02-24 | — | — | WO | claimed |
| WO-2005016883-A2 | ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF | ICOS CORPORATION (US) | 2005-02-24 | — | — | WO | disclosed |